Improving Outpatient Endometrial Biopsy Results
NCT06694246 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2024-12-04
Summary
Pipelle is the most commonly used outpatient endometrial biopsy device. Pipelle endometrial biopsy can diagnose 90% of endometrial cancer cases. Pipelle endometrial biopsy is one of the first-line diagnostic procedures for women presenting with abnormal peri- and post-menopausal vaginal bleeding.
Insufficient samples are obtained in 5-23% of cases. In Adan Hospital, a retrospective analysis of all outpatient endometrial samples sent to the histopathology department from April- to October 2024 study showed an insufficient sample percentage of 32% This may be attributed to factors such as patients, equipment, and physicians.
This project aims to improve the endometrial biopsy results by Identifying these factors in the Adan hospital setting, Implementing measures to modify these factors, and finally re-auditing the endometrial biopsy results after six months.
Conditions
- Histopathology
- Screening Tool
- Techniques
Interventions
- OTHER
-
Improving technique
A checklist was developed to ensure the important steps were followed, with tips for obtaining a more adequate sample. This checklist was put in the outpatient procedures room, and each physician performing a biopsy was asked to fill it out. Also, a diagram containing illustrative images with the basic steps was put in the procedures room. The topic was covered in the biweekly scientific meeting, and all factors attributed to the inadequate sample were discussed. The department lead mentioned the topic in the OBGYN department's private messaging group. It was finally mentioned in the morning meeting.
- OTHER
-
Using hysteroscopy in candidate patients
Patients with focal lesions on ultrasound will undergo hysteroscopy and biopsy instead of blind endometrial sampling. Patient with stenosed cervix or failed previous sampling might also undergo hysteroscopic guided biopsy.
- OTHER
-
Analgesia
Analgesia in the form of paracetamol or NSAIDs might be given to some patients 30- 60 minutes before the procedure to reduce the procedure-associated pain and the resultant failure to complete it and obtain an adequate sample.
Sponsors & Collaborators
-
Al Adan Hospital Kuwait
collaborator INDUSTRY -
Cairo University
lead OTHER
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-01
- Primary Completion
- 2025-04-30
- Completion
- 2025-04-30
Countries
- Kuwait
More Related Trials
-
Generation of Endometrial Carcinoma Organoids
NCT07258186 ·Status: RECRUITING
-
Endometrial Changes in Breast Cancer Women.
NCT05717634 ·Status: UNKNOWN
-
Screening of Biomarkers on Endometrial Cancers
NCT00674349 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study for the Generation of Cervical Cancer Organoids From Patients Undergoing Diagnostic Biopsy
NCT07248878 ·Status: RECRUITING
-
A Novel Tapered Applicator for Vaginal Vault Brachytherapy
NCT04318340 ·Status: COMPLETED ·Phase: NA
-
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
NCT05049538 ·Status: RECRUITING
-
Conservative Treatment for Atypical Endometrial Hyperplasia and Early Endometrial Cancer
NCT06170684 ·Status: NOT_YET_RECRUITING
-
Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
NCT03593681 ·Status: COMPLETED
-
Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and Specificity
NCT02518256 ·Status: COMPLETED ·Phase: NA
-
Benign Reproductive Tissue Analysis for Endometrial Cancer Markers
NCT00481754 ·Status: COMPLETED
-
Studies on the H Pipelle, a New Device for Endometrial Sampling at Hysteroscopy
NCT00755651 ·Status: COMPLETED ·Phase: NA
-
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer
NCT05139368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
NCT04570553 ·Status: RECRUITING ·Phase: NA
-
The Effect of Androgen Receptor Polymorphism on Endometrial Cancer
NCT05157373 ·Status: UNKNOWN
-
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
NCT06365905 ·Status: RECRUITING
-
Collecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442 ·Status: COMPLETED
-
Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.
NCT02062697 ·Status: COMPLETED ·Phase: NA
-
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
NCT06672341 ·Status: NOT_YET_RECRUITING
-
Fertility Preservation in Female Cancer Patients
NCT01268592 ·Status: TERMINATED ·Phase: NA
-
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma
NCT00165126 ·Status: COMPLETED
-
Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue
NCT03498924 ·Status: COMPLETED
-
Endocervical Evaluation With the Curette Versus Cytobrush for the Diagnosis of Dysplasia of the Uterine Cervix
NCT01435590 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Tumor Tissue Samples From Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
NCT01164735 ·Status: COMPLETED
-
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
NCT00339651 ·Status: COMPLETED
-
Imaging the Uterine Cervix - UltraSightHD™
NCT01090635 ·Status: COMPLETED